Functional Comparison of Blood-Stage Plasmodium falciparum Malaria Vaccine Candidate Antigens
Joseph J. Illingworth(University of Oxford), Simon J. Draper(University of Oxford), Helen Bartlett(University of Oxford), Daniel G. W. Alanine(University of Oxford), David J. Pattinson(University of Oxford), Matthew K. Higgins(University of Oxford), Doris Quinkert(University of Oxford), Katherine E. Wright(Memorial Hermann), Sarah E. Silk(University of Oxford), Michael W. Shea(University of Oxford), Alexander D. Douglas(University of Oxford), Jason Wendler(Pacific Northwest National Laboratory), Geneviève M. Labbé(University of Oxford), Rebecca Brown(University of Oxford), Jennifer M. Marshall(University of Oxford), Simone C. de Cassan(University of Oxford), Jee Sun Cho(University of Oxford), Lea Barfod(University of Copenhagen)
Cited by 50
Related Papers
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial
|The Lancet|2020|2.6k
T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial
|Nature Medicine|2020|643
Evidence for the Involvement of VAR2CSA in Pregnancy-associated Malaria
|The Journal of Experimental Medicine|2004|615
Severe malaria is associated with parasite binding to endothelial protein C receptor
|Nature|2013|579
Plug-and-Display: decoration of Virus-Like Particles via isopeptide bonds for modular immunization
|Scientific Reports|2016|438